Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
(4-(Morpholin-4-yl)phenyl)boronic acid → Tert-butyl 3-hydroxy-5-((7-(4-morpholinophenyl)pyrido[4,3-b]pyrazin-5-ylamino)methyl)piperidine-1-carboxylate
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | (4-(Morpholin-4-yl)phenyl)boronic acid | HCID 2795359 | — |
| 반응물 | Tert-butyl 3-((7-chloropyrido[4,3-b]pyrazin-5-ylamino)methyl)-5-hydroxypiperidine-1-carboxylate | HCID 86717368 | — |
| 생성물 | Tert-butyl 3-hydroxy-5-((7-(4-morpholinophenyl)pyrido[4,3-b]pyrazin-5-ylamino)methyl)piperidine-1-carboxylate | HCID 71113447 | — |
반응 단계
The title compound was prepared according to the procedures of Compound 1 (B) using tert-butyl 3-((7-chloropyrido[4,3-b]pyrazin-5-ylamino)methyl)-5-hydroxypiperidine-1-carboxylate and 4-morpholinophenylboronic acid. MS (m/z): 521 (M+H)+.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US09434726B2 |
| 출처 데이터셋 | uspto-grants-2016_09 |
| ORD ID | ord-e599baed4a414dda88e024d000d4e251 |
| 출처 메모 | uspto-grants-2016_09 |